Different uptake kinetics of PSMA ligands in kidneys than in prostate cancer have been reported by two different groups during preclinical experiments [23, 24] and the respective authors discussed that a reduced rate of cellular internalization in renal cells would explain these observations. Here, FOLH1 is linked to prostate cancer.